313 related articles for article (PubMed ID: 19745687)
1. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
[TBL] [Abstract][Full Text] [Related]
2. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
4. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
5. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
[TBL] [Abstract][Full Text] [Related]
7. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.
Fragkioudaki S; Mavragani CP; Moutsopoulos HM
Medicine (Baltimore); 2016 Jun; 95(25):e3766. PubMed ID: 27336863
[TBL] [Abstract][Full Text] [Related]
8. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
9. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.
Skopouli FN; Dafni U; Ioannidis JP; Moutsopoulos HM
Semin Arthritis Rheum; 2000 Apr; 29(5):296-304. PubMed ID: 10805354
[TBL] [Abstract][Full Text] [Related]
10. Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.
Nishishinya MB; Pereda CA; Muñoz-Fernández S; Pego-Reigosa JM; Rúa-Figueroa I; Andreu JL; Fernández-Castro M; Rosas J; Loza Santamaría E
Rheumatol Int; 2015 Jan; 35(1):17-26. PubMed ID: 24899571
[TBL] [Abstract][Full Text] [Related]
11. Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS.
Zufferey P; Meyer OC; Grossin M; Kahn MF
Scand J Rheumatol; 1995; 24(6):342-5. PubMed ID: 8610217
[TBL] [Abstract][Full Text] [Related]
12. Hematologic manifestations of primary Sjögren's syndrome.
Manganelli P; Fietta P; Quaini F
Clin Exp Rheumatol; 2006; 24(4):438-48. PubMed ID: 16956437
[TBL] [Abstract][Full Text] [Related]
13. [Gougerot-Sjögren syndrome and malignant lymphoproliferative syndromes].
Grosbois B; Jego P; Leblay R
Rev Med Interne; 1998 May; 19(5):319-24. PubMed ID: 9775165
[TBL] [Abstract][Full Text] [Related]
14. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
[TBL] [Abstract][Full Text] [Related]
15. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
16. Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome.
Jonsson MV; Theander E; Jonsson R
Presse Med; 2012 Sep; 41(9 Pt 2):e511-6. PubMed ID: 22867948
[TBL] [Abstract][Full Text] [Related]
17. Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981-2021).
Chatzis LG; Stergiou IE; Goules AV; Pezoulas V; Tsourouflis G; Fotiadis D; Tzioufas AG; Voulgarelis M
Rheumatology (Oxford); 2022 Aug; 61(9):3576-3585. PubMed ID: 34940812
[TBL] [Abstract][Full Text] [Related]
18. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome.
Brito-Zerón P; Kostov B; Fraile G; Caravia-Durán D; Maure B; Rascón FJ; Zamora M; Casanovas A; Lopez-Dupla M; Ripoll M; Pinilla B; Fonseca E; Akasbi M; de la Red G; Duarte-Millán MA; Fanlo P; Guisado-Vasco P; Pérez-Alvarez R; Chamorro AJ; Morcillo C; Jiménez-Heredia I; Sánchez-Berná I; López-Guillermo A; Ramos-Casals M;
J Hematol Oncol; 2017 Apr; 10(1):90. PubMed ID: 28416003
[TBL] [Abstract][Full Text] [Related]
19. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
[TBL] [Abstract][Full Text] [Related]
20. Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia.
Ismail F; Mahmoud A; Abdelhaleem H; Mamdoh A; Geneidy M; Kamal E
Rheumatol Int; 2013 Apr; 33(4):1021-5. PubMed ID: 22886469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
